WHO WE ARE
CalChem Synthesis is a Contract Research Organization (CRO) serving as an outsourcing partner for the biotech and pharmaceutical companies and research institutions.
Our leadership team has over 35 years of combined experience in different sectors of drug discovery and development in pharma industry.
Our mission is to set the highest standards in providing quality chemistry services at competitive prices to pharmaceutical and biotech companies for development of new drugs to cure diseases and promote better health for patients.
The chemistry activities at CalChem Synthesis are directed by Ph.D. level organic chemists with combined 35 years of experience in the pharmaceutical and chemical industries.
CalChem Synthesis (Where Chemistry makes a difference!)
CalChem Synthesis is a Contract Research Organization (CRO) serving as an outsourcing partner for the biotech and pharmaceutical companies and research institutions. Founded by Dr. Jalal Haddad, the co-founder of Pacific World Discovery, and a process research and development scientist at Albany Molecular Research, Inc. (AMRI), the company mission is to provide high quality non-GMP chemistry services to the chemical community and to maintain customer satisfaction. Our services are based on the belief that our customers’ needs are of the utmost importance and we are committed to meeting those needs. The experience of CalChem’s team in synthetic organic chemistry and process research Continue Reading...
FDA Drug Safety Podcast: FDA evaluating the risk of burns and scars with Zecuity (sumatriptan) migraine patch
Welcome to FDA Drug Safety Podcasts for health care professionals. This is Lesley Navin, Advanced Practice Nurse from the Division of Drug Information. On June 2, 2016, FDA announced it is investigating the risk of serious burns and potential permanent scarring with the use of Zecuity (sumatriptan iontophoretic transdermal system)...Read more